Gelžmedis - Company finances
|
EUR
|
2024
From: 2024-08-12
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 10,306 | 8,290 |
| Profit before tax | 2,154 | -1,023 |
| Net profit | 2,154 | -1,023 |
| Equity | 2,067 | 800 |
| Liabilities | 81 | 130 |
| Non-current assets | 1,324 | 866 |
| Current assets | 824 | 64 |
| Total assets | 2,148 | 930 |
|
Taxes paid
|
||
| STI taxes | - | 3 |
|
Financial indicators
|
||
| Revenue change y/y | - | -19.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 100.3% | -110.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 104.2% | -127.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 20.9% | -12.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 20.9% | -12.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Gelžmedis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-10-01 | 2025-10-31 | 72.45 |
| 2025-06-03 | 2025-06-30 | 72.45 |
| 2025-02-01 | 2025-02-28 | 72.45 |
Gelžmedis - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-17 | 2026-03-18 | 9.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Gelžmedis, MB (code 306969685) is a Lithuanian small partnership engaged in the manufacture of metal structures and parts of structures. In 2025, the latest financial year, the company generated €8.3K in revenue, down 19.6% year on year from €10.3K in 2024. Profitability also weakened materially: after recording a net profit of €2.2K in 2024, the company posted a net loss of €1.0K in 2025, with the net margin turning to -12.3%. The 2024 result was profitable, while 2025 shows a clear reversal in operating performance. The balance sheet remained very small, with total assets of €930 at year-end 2025, equity of €800 and liabilities of €130. Equity accounted for 86.0% of assets, while debt-to-equity stood at 0.16. Asset turnover was 8.91x, indicating that revenue was generated from a very limited asset base. Return ratios were negative in 2025, but they are amplified by the small size of equity and assets and should be read in that context.